Use of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision-Making Between Patients With Cancer and Clinicians.

Autor: Singh N; University of Washington, Seattle., Grivas P; University of Washington and Fred Hutchinson Cancer Center, Seattle., Makris UE; University of Texas Southwestern Medical Center, Dallas., Suarez-Almazor ME; The University of Texas MD Anderson Cancer Center, Houston., O'Hare AM; Department of Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle., Barton JL; Oregon Health and Science University and Department of Veterans Affairs Portland Health Care System, Portland.
Jazyk: angličtina
Zdroj: ACR open rheumatology [ACR Open Rheumatol] 2023 Jun; Vol. 5 (6), pp. 305-307. Date of Electronic Publication: 2023 May 11.
DOI: 10.1002/acr2.11552
Databáze: MEDLINE